These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36737716)

  • 1. Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson's: a study protocol.
    Sigurdsson HP; Hunter H; Alcock L; Wilson R; Pienaar I; Want E; Baker MR; Taylor JP; Rochester L; Yarnall AJ
    BMC Neurol; 2023 Feb; 23(1):58. PubMed ID: 36737716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive vagus nerve stimulation in Parkinson's disease: current status and future prospects.
    Sigurdsson HP; Raw R; Hunter H; Baker MR; Taylor JP; Rochester L; Yarnall AJ
    Expert Rev Med Devices; 2021 Oct; 18(10):971-984. PubMed ID: 34461787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of transcutaneous vagus nerve stimulation in mild cognitive impairment: VINCI-AD study protocol.
    Dolphin H; Dyer AH; Dukelow T; Finucane C; Commins S; Kennelly SP
    BMC Neurol; 2023 Aug; 23(1):289. PubMed ID: 37532979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study.
    Zhang H; Cao XY; Wang LN; Tong Q; Sun HM; Gan CT; Shan AD; Yuan YS; Zhang KZ
    CNS Neurosci Ther; 2023 Dec; 29(12):3889-3900. PubMed ID: 37311693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
    Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
    J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson's disease.
    Mondal B; Choudhury S; Banerjee R; Roy A; Chatterjee K; Basu P; Singh R; Halder S; Shubham S; Baker SN; Baker MR; Kumar H
    Front Aging Neurosci; 2023; 15():1331575. PubMed ID: 38384731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transcranial direct current stimulation on gait in people with Parkinson's disease: study protocol for a randomized, controlled clinical trial.
    Alizad V; Meinzer M; Frossard L; Polman R; Smith S; Kerr G
    Trials; 2018 Nov; 19(1):661. PubMed ID: 30486849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.
    Goadsby PJ; de Coo IF; Silver N; Tyagi A; Ahmed F; Gaul C; Jensen RH; Diener HC; Solbach K; Straube A; Liebler E; Marin JC; Ferrari MD;
    Cephalalgia; 2018 Apr; 38(5):959-969. PubMed ID: 29231763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Vagus Stimulation Modulates Contralateral Subthalamic β Power Improving the Gait in Parkinson's Disease.
    Marano M; Anzini G; Saltarocchi L; Ricciuti R; Capone F; Tan H; Torrecillos F; Lanzone J; Di Lazzaro V
    Mov Disord; 2024 Feb; 39(2):424-428. PubMed ID: 38111224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke.
    Arsava EM; Topcuoglu MA; Ay I; Ozdemir AO; Gungor IL; Togay Isikay C; Nazliel B; Kozak HH; Ozturk S; Yilmaz İA; Dora B; Ay H;
    Brain Stimul; 2022; 15(6):1467-1474. PubMed ID: 36356829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson's disease in patients with freezing of gait.
    Mondal B; Choudhury S; Banerjee R; Roy A; Chatterjee K; Basu P; Singh R; Halder S; Shubham S; Baker SN; Baker MR; Kumar H
    NPJ Parkinsons Dis; 2021 May; 7(1):46. PubMed ID: 34045464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Diener HC; Goadsby PJ; Ashina M; Al-Karagholi MA; Sinclair A; Mitsikostas D; Magis D; Pozo-Rosich P; Irimia Sieira P; Làinez MJ; Gaul C; Silver N; Hoffmann J; Marin J; Liebler E; Ferrari MD
    Cephalalgia; 2019 Oct; 39(12):1475-1487. PubMed ID: 31522546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
    Grazzi L; Tassorelli C; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
    J Headache Pain; 2018 Oct; 19(1):98. PubMed ID: 30340460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
    Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ;
    Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vagus nerve stimulation for partial seizures.
    Panebianco M; Rigby A; Weston J; Marson AG
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD002896. PubMed ID: 25835947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial.
    Lerman I; Hauger R; Sorkin L; Proudfoot J; Davis B; Huang A; Lam K; Simon B; Baker DG
    Neuromodulation; 2016 Apr; 19(3):283-90. PubMed ID: 26990318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson's Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson's disease using a self-contained wearable device.
    Smith MD; Tenison E; Drake MJ; Ben-Shlomo Y; Henderson EJ
    Trials; 2022 Oct; 23(1):912. PubMed ID: 36307874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy.
    Lench DH; Turner TH; McLeod C; Boger HA; Lovera L; Heidelberg L; Elm J; Phan A; Badran BW; Hinson VK
    Front Neurol; 2023; 14():1210103. PubMed ID: 37554394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial.
    He W; Wang XY; Zhou L; Li ZM; Jing XH; Lv ZL; Zhao YF; Shi H; Hu L; Su YS; Zhu B
    Trials; 2015 Aug; 16():371. PubMed ID: 26292720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.